News

Here you will find our latest news and updates.

July 2019 updates to website

Uncategorized

The website has now been updated following July’s LMMG

The following drugs have been added/updated:

Brivaracetam — Adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in adult, adolescents and children from 4 years of age with epilepsy

Stiripentol — Adjunctive therapy of refractory generalised tonic-clonic seizures in patients with severe myoclonic epilepsy in infancy (Dravet syndrome) in combination with clobazam and valproate (under expert supervision)

Ertugliflozin with metformin and a dipeptidyl peptidase‑4 inhibitor — Treating type 2 diabetes (NICE TA583)

Ocrelizumab — Treating Primary Progressive Multiple Sclerosis (NICE TA585)

Aliskiren — Essential hypertension

Minocycline — Susceptible infections

Bath & Shower Preparations — Dry & Pruritic Skin Conditions

Hormone Therapy — Gender Dysphoria

The following guidelines have been added/updated:

Trans-male and female Gender Dysphoria — Information Sheet — New

Camouflaging Products — Position Statement — New

Chronic Non-Cancer Pain — Guideline — Update

Testosterone — Shared Care — Update